newsfilter
← Latest News
GlobeNewswire·

Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-